Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science


Family Practice (Primary Care)


Dr. Mary Walton



The treatment of opioid use disorder in correctional medicine is a relatively novel concept that has become increasingly adopted over the last several years across the United States. Daily sublingual buprenorphine has been widely accepted as a first-line medication; however, the long-acting injectable formulation of buprenorphine may be a more effective option for treating incarcerated patients. The long-acting formulation of buprenorphine is superior to daily sublingual buprenorphine in terms of patient compliance and treatment retention post-release, less frequent dosing, decreased diversion risk in the prison, and reduced patient care episodes as well as staff involvement following the initiation of care.


Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.